Posttranscriptional Regulation of by MiR-124-3p at Rs3512 Underlies Onset-delaying Genetic Modification in Huntington's Disease
Overview
Authors
Affiliations
Many Mendelian disorders, such as Huntington's disease (HD) and spinocerebellar ataxias, arise from expansions of CAG trinucleotide repeats. Despite the clear genetic causes, additional genetic factors may influence the rate of those monogenic disorders. Notably, genome-wide association studies discovered somewhat expected modifiers, particularly mismatch repair genes involved in the CAG repeat instability, impacting age at onset of HD. Strikingly, , previously unrelated to repeat instability, produced the strongest HD modification signals. Diverse haplotypes independently modify HD, with rare genetic variants diminishing DNA binding or nuclease activity of the FAN1 protein, hastening HD onset. However, the mechanism behind the frequent and the most significant onset-delaying haplotype lacking missense variations has remained elusive. Here, we illustrated that a microRNA acting on 3'-UTR (untranslated region) SNP rs3512, rather than transcriptional regulation, is responsible for the significant expression quantitative trait loci signal and allelic imbalance in messenger ribonucleic acid (mRNA), accounting for the most significant and frequent onset-delaying modifier haplotype in HD. Specifically, miR-124-3p selectively targets the reference allele at rs3512, diminishing the stability of mRNA harboring that allele and consequently reducing its levels. Subsequent validation analyses, including the use of antagomir and 3'-UTR reporter vectors with swapped alleles, confirmed the specificity of miR-124-3p at rs3512. Together, these findings indicate that the alternative allele at rs3512 renders the mRNA less susceptible to miR-124-3p-mediated posttranscriptional regulation, resulting in increased FAN1 levels and a subsequent delay in HD onset by mitigating CAG repeat instability.
Transcriptome Study in Sicilian Patients with Huntington's Disease.
Salemi M, Di Stefano V, Schillaci F, Marchese G, Salluzzo M, Cordella A Diagnostics (Basel). 2025; 15(4).
PMID: 40002561 PMC: 11854416. DOI: 10.3390/diagnostics15040409.
Li Y, Chen S, Rao H, Cui S, Chen G Adv Sci (Weinh). 2025; 12(7):e2414625.
PMID: 39836690 PMC: 11831481. DOI: 10.1002/advs.202414625.
RNA gain-of-function mechanisms in short tandem repeat diseases.
Davenport M, Swanson M RNA. 2024; 31(3):349-358.
PMID: 39725460 PMC: 11874975. DOI: 10.1261/rna.080277.124.
miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis.
Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S Commun Biol. 2024; 7(1):1393.
PMID: 39455851 PMC: 11511827. DOI: 10.1038/s42003-024-07089-2.